Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Healthcare Sector Analysis

UpdatedJun 05, 2026
DataAggregated Company Financials
Companies1402
  • 7D0.2%
  • 3M1.5%
  • 1Y16.6%
  • YTD-1.7%

The Healthcare is pretty flat in the last 7 days, but UnitedHealth Group has stood out, gaining 3.6%. As for the the longer term, the industry is up 17% over the past 12 months. Looking forward, earnings are forecast to grow by 18% annually.

Sector Valuation and Performance

Has the U.S. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 05 Jun 2026US$6.3tUS$3.3tUS$122.7b23.7x51x1.9x
Sun, 03 May 2026US$6.2tUS$3.3tUS$118.0b23.6x52.4x1.9x
Tue, 31 Mar 2026US$6.0tUS$3.3tUS$126.5b21.9x47.3x1.8x
Thu, 26 Feb 2026US$6.6tUS$3.3tUS$126.3b26.2x52.2x2x
Sat, 24 Jan 2026US$6.7tUS$3.2tUS$130.6b28.5x51.1x2.1x
Mon, 22 Dec 2025US$6.5tUS$3.2tUS$135.2b26.2x48x2x
Wed, 19 Nov 2025US$6.2tUS$3.2tUS$133.4b25.1x46.8x2x
Fri, 17 Oct 2025US$6.0tUS$3.1tUS$140.4b25.4x42.5x1.9x
Sun, 14 Sep 2025US$5.7tUS$3.1tUS$137.6b22.7x41.6x1.9x
Tue, 12 Aug 2025US$5.4tUS$3.1tUS$139.8b23.4x38.5x1.7x
Thu, 10 Jul 2025US$5.5tUS$3.0tUS$127.9b24.2x43.2x1.8x
Sat, 07 Jun 2025US$5.4tUS$3.0tUS$127.2b24x42.7x1.8x
Mon, 05 May 2025US$5.6tUS$2.7tUS$126.2b24.8x44.1x2x
Wed, 02 Apr 2025US$5.7tUS$2.6tUS$81.6b26.3x69.4x2.1x
Fri, 28 Feb 2025US$5.8tUS$2.6tUS$79.7b26.1x73.3x2.2x
Sun, 26 Jan 2025US$6.0tUS$2.9tUS$85.5b27.9x70.7x2.1x
Tue, 24 Dec 2024US$5.8tUS$2.9tUS$78.3b27.1x73.5x2x
Thu, 21 Nov 2024US$5.9tUS$2.9tUS$77.0b27.4x76.7x2x
Sat, 19 Oct 2024US$6.2tUS$2.8tUS$58.7b32.2x105.7x2.2x
Mon, 16 Sep 2024US$6.3tUS$2.8tUS$60.0b30.6x105.4x2.2x
Wed, 14 Aug 2024US$6.0tUS$2.8tUS$55.4b31.1x108.3x2.1x
Fri, 12 Jul 2024US$6.2tUS$2.8tUS$62.2b30.7x100x2.2x
Sun, 09 Jun 2024US$6.2tUS$2.8tUS$63.6b30x97.5x2.2x
Tue, 07 May 2024US$6.1tUS$2.8tUS$64.3b31.1x94.4x2.1x
Thu, 04 Apr 2024US$6.2tUS$2.8tUS$84.0b32.4x73.6x2.2x
Sat, 02 Mar 2024US$6.2tUS$2.8tUS$85.1b31.9x73.3x2.2x
Mon, 29 Jan 2024US$6.3tUS$2.8tUS$90.7b32x69.7x2.2x
Wed, 27 Dec 2023US$6.2tUS$2.8tUS$91.5b33x67.4x2.2x
Fri, 24 Nov 2023US$5.8tUS$2.8tUS$91.2b28.2x63.8x2.1x
Sun, 22 Oct 2023US$5.7tUS$2.8tUS$99.6b25.6x57.7x2.1x
Tue, 19 Sep 2023US$6.0tUS$2.8tUS$98.6b29.1x60.8x2.2x
Thu, 17 Aug 2023US$6.1tUS$2.8tUS$99.2b28.7x61.9x2.2x
Sat, 15 Jul 2023US$6.0tUS$2.7tUS$110.9b26.3x53.9x2.2x
Mon, 12 Jun 2023US$6.0tUS$2.7tUS$110.4b25.2x53.9x2.2x
Price to Earnings Ratio

53.9x


Total Market Cap: US$6.0tTotal Earnings: US$110.4bTotal Revenue: US$2.7tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Healthcare Sector Price to Earnings3Y Average 65.5x202420252026
Current Industry PE
  • Investors are pessimistic on the American Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 51.0x which is lower than its 3-year average PE of 65.5x.
  • The industry is trading close to its 3-year average PS ratio of 2.1x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 3.6% per year over the last three years.
  • Revenues for these companies have grown 7.0% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare sector?

US Market-0.11%
Healthcare0.24%
Healthtech5.10%
Healthcare Services2.16%
Life Sciences2.02%
Medical Equipment1.03%
Pharma-0.52%
Biotech-1.41%
Industry PE
  • Investors are most optimistic about the Life Sciences industry even though it's trading below its 3-year average PE ratio of 56.4x.
    • Analysts are expecting annual earnings growth of 17.2%, which is higher than its past year's earnings growth of 5.2% per year.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 25% over the next 5 years.
  • However this is lower than its past earnings growth rate of 55% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 15% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
UNH UnitedHealth GroupUS$396.473.6%
+US$12.7b		34.0%PE29.9x
ABBV AbbVieUS$224.942.9%
+US$11.1b		20.0%PE110.5x
MDT MedtronicUS$81.938.4%
+US$8.2b		-5.8%PE21.9x
ABT Abbott LaboratoriesUS$90.785.2%
+US$7.8b		-32.2%PE25.3x
HUM HumanaUS$349.8013.3%
+US$4.9b		54.0%PE37.2x

Latest News

MDT
US$81.93
Medtronic
7D
8.4%
1Y
-5.8%
SYK
US$301.21
Stryker
7D
-2.1%
1Y
-21.4%
UNH
US$396.47
UnitedHealth Group
7D
3.6%
1Y
34.0%
GILD
US$129.18
Gilead Sciences
7D
-5.2%
1Y
16.9%
JNJ
US$228.17
Johnson & Johnson
7D
-1.1%
1Y
48.5%
ABT
US$90.78
Abbott Laboratories
7D
5.2%
1Y
-32.2%
AMGN
US$345.60
Amgen
7D
2.7%
1Y
20.4%
ABBV
US$224.94
AbbVie
7D
2.9%
1Y
20.0%
ELV
US$409.44
Elevance Health
7D
4.2%
1Y
6.4%
DHR
US$186.64
Danaher
7D
3.3%
1Y
-2.9%
PRAX
US$264.75
Praxis Precision Medicines
7D
-24.9%
1Y
526.5%
SMMT
US$14.84
Summit Therapeutics
7D
-14.8%
1Y
-24.8%
PFE
US$25.69
Pfizer
7D
-1.7%
1Y
11.1%
HCA
US$361.83
HCA Healthcare
7D
-5.9%
1Y
-5.2%
Narrative Update • Jun 02

HCA: Georgia Medicaid SDP And CMS Rule Will Shape Future Upside

Analysts trimmed the fair value estimate for HCA Healthcare by about $2 to $510.95, as modestly higher discount rate assumptions and updated views on the proposed CMS Medicaid payment rule outweighed small adjustments to revenue growth, profit margin, and future P/E inputs. Analyst Commentary Recent Street research around HCA Healthcare has focused on the evolving Medicaid policy backdrop and recalibrated valuation targets.
MDLN
US$34.45
Medline
7D
-6.4%
1Y
n/a
HUM
US$349.80
Humana
7D
13.3%
1Y
54.0%